Pharmacological Reduction of Portal Pressure and Long-Term Risk of First Variceal Bleeding in Patients with Cirrhosis

No abstract is available for this paper.

• Publication year

  2006

• Venue

  American Journal of Gastroenterology

• Publication date

  2006-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1572-0241.2006.00453.xPMID 16542287
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis.

  2004cited by this paper
• Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications

  2004cited by this paper
• Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients.

  2004cited by this paper
• Monitoring target reduction in hepatic venous pressure gradient during pharmacological therapy of portal hypertension: a close look at the evidence

  2003cited by this paper
• Hemodynamic response to pharmacological treatment of portal hypertension and long‐term prognosis of cirrhosis

  2003cited by this paper
• Propranolol plus placebo versus propranolol plus isosorbide‐5‐mononitrate in the prevention of a first variceal bleed: A double‐blind RCT

  2003cited by this paper
• Randomized comparison of long‐term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis

  2002cited by this paper
• “A la carte” treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding

  2002cited by this paper
• Propranolol for the prevention of first esophageal variceal hemorrhage: A lifetime commitment?

  2001cited by this paper
• Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding.

  2001cited by this paper
• The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis

  2000cited by this paper
• Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club.

  2000cited by this paper
• Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites

  2000cited by this paper
• Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension

  2000cited by this paper
• Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension.

  2000cited by this paper
• Pharmacological Treatment of Portal Hypertension: An Evidence-Based Approach

  1999cited by this paper
• Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings.

  1998cited by this paper
• Portal hypertension and variceal bleeding: An AASLD single topic symposium

  1998cited by this paper
• Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites.

  1997cited by this paper
• Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding.

  1996cited by this paper
• Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis.

  1995cited by this paper
• Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites.

  1995cited by this paper
• The Risk of Determining Risk with Multivariable Models

  1993cited by this paper
• Bacterial translocation in acute and chronic portal hypertension

  1993cited by this paper
• Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage.

  1990cited by this paper
• Compensated cirrhosis: Natural history and prognostic factors

  1987cited by this paper
• Hemodynamic Evaluation of the Patient with Portal Hypertension

  1986cited by this paper
• Portal pressure, presence of gastroesophageal varices and variceal bleeding

  1985cited by this paper
• Prediction of variceal hemorrhage by esophageal endoscopy.

  1981cited by this paper
• Hemodynamic evaluation of patients with intrahepatic portal hypertension. Relationship between bleeding varices and the portohepatic gradient.

  1975cited by this paper

• The Use of Non‐Selective Beta‐Blockers in Cirrhotic Portal Hypertension

  2026cites this paper
• Prognostic Role of Endoscopic Ultrasound Guided Direct Portal Pressure Gradient Measurement in Porto‐Sinusoidal Vascular Disorder

  2025cites this paper
• The effect of propranolol on gastrointestinal motility and permeability in patients with cirrhosis and significant portal hypertension

  2024cites this paper
• Hepatic Venous Pressure Gradient

  2024cites this paper
• Optimal resting heart rate and ascites‐related death in patients with cirrhosis and ascites using nonselective beta‐blockers (ORCA)

  2023cites this paper
• The Role of Endoscopy for Primary and Secondary Prophylaxis of Variceal Bleeding.

  2023cites this paper
• β-Blockers in Hepatosplenic Schistosomiasis: A Narrative Review.

  2023cites this paper
• Portal Hypertension in Children: A Tertiary Center Experience in Turkey

  2023cites this paper
• Spleen Transient Elastography and Damping Index Identify a Subgroup of Patients Without an Acute or Chronic Response to Beta-Blockers

  2022cites this paper
• Liver Fibrosis, Liver Cancer, and Advances in Therapeutic Approaches

  2022cites this paper
• Non‐selective beta‐blockers in patients with ascites: The complex interplay among the liver, kidney and heart

  2022cites this paper
• Endovascular Assessment of Liver Hemodynamics in Cirrhotic Patients with Portal Hypertension.

  2022cites this paper
• Platelet Count/Spleen Thickness Ratio and the Risk of Variceal Bleeding in Cirrhosis With Esophagogastric Varices

  2022cites this paper
• The Effect of Statin Therapy on Mortality in Adult Patients with Liver Cirrhosis: An Evidence-Based Case Report.

  2022cites this paper
• Portal Hypertension in Children

  2021cites this paper
• Indian College of Radiology and Imaging Evidence-Based Guidelines for Interventions in Portal Hypertension and Its Complications

  2021cites this paper
• Portal Hypertension and Ascites: Patient-and Population-centered Clinical Practice Guidelines by the Italian Association for the Study of the Liver (AISF).

  2021cites this paper
• Outcomes of Portal Pressure-Guided Therapy in Decompensated Cirrhosis With Index Variceal Bleed in Asian Cohort.

  2021cites this paper
• Editorial: non‐selective beta blockers—in and out of circulation. Authors' reply

  2021cites this paper
• A new prognostic algorithm based on stage of cirrhosis and HVPG to improve risk-stratification after variceal bleeding.

  2020cites this paper
• Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-Analysis.

  2020cites this paper
• Endoscopic variceal ligation as primary prophylaxis for upper GI bleeding in children.

  2020cites this paper
• A Prognostic Strategy Based on Stage of Cirrhosis and HVPG to Improve Risk Stratification After Variceal Bleeding

  2020cites this paper
• Beta-blockers and Statins: Role in Portal Hypertension and Beyond

  2020cites this paper
• Precision medicine in variceal bleeding: Are we there yet?

  2020cites this paper
• Non‐selective beta‐blocker use in cirrhotic patients is associated with a reduced likelihood of hospitalisation for infection

  2020cites this paper
• Part 1: Disease of the Heart and Liver

  2020cites this paper
• Beta-blockers in cirrhosis: Do they have benefits beyond the prevention of variceal bleeding?

  2019cites this paper
• CLINICAL UTILITY OF RISK SCORES IN VARICEAL BLEEDING.

  2019cites this paper
• Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices.

  2019cites this paper
• Role of Beta Blockers and Band Ligation in upper gastrointestinal tract bleeding.

  2019cites this paper
• Carvedilol vs endoscopic variceal ligation for primary and secondary prevention of variceal bleeding: Systematic review and meta-analysis

  2019cites this paper
• Portal Hypertension

  2019cites this paper
• Hepatic Venous Pressure Gradient Response in Non-Selective Beta-Blocker Treatment—Is It Worth Measuring?

  2019cites this paper
• Clinical Investigation of Portal Hypertension

  2019influential citation
• Treatment with carvedilol improves survival of patients with acute-on-chronic liver failure: a randomized controlled trial

  2019cites this paper
• HVPG Measurements as a Surrogate of Clinical Events in Cirrhosis: Experience from Clinical Trials

  2019cites this paper
• Conservative Treatment: Pharmacological Therapy

  2019cites this paper
• Portal Hypertension and Related Complications: Diagnosis and Management

  2019cites this paper
• Beta-blockers in cirrhosis: Evidence-based indications and limitations

  2019cites this paper
• Liver volume index predicts the risk of esophageal variceal hemorrhage in cirrhotic patients on propranolol prophylaxis

  2019cites this paper
• Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices.

  2018cites this paper
• Pharmacologic prevention of variceal bleeding and rebleeding

  2018cites this paper
• Small Esophageal Varices in Patients with Cirrhosis—Should We Treat Them?

  2018cites this paper
• IMPACT OF NON-SELECTIVE BETA-BLOCKERS IN ADVANCED CIRRHOSIS

  2018cites this paper
• Treating Other Symptoms of Wilson Disease: The Liver

  2018cites this paper
• Management of Wilson Disease

  2018cites this paper
• Hepatic Venous Pressure Measurement and Other Diagnostic Hepatic Hemodynamic Techniques

  2018cites this paper
• Dose-dependent effect of propranolol on the hemodynamic response in cirrhotic patients with gastroesophageal varices

  2018cites this paper
• Impact of an acute hemodynamic response-guided protocol for primary prophylaxis of variceal bleeding

  2018cites this paper
• Evaluation of portal hypertension in the cirrhotic patient: hepatic vein pressure gradient and beyond

  2018cites this paper
• Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding

  2018cites this paper
• Hemodynamic response to primary prophylactic therapy with nonselective &bgr;-blockers is related to a reduction of first variceal bleeding risk in liver cirrhosis: a meta-analysis

  2017cites this paper
• Pediatric gastrointestinal bleeding: Perspectives from the Italian Society of Pediatric Gastroenterology

  2017cites this paper
• Favorable Effects of Endoscopic Ligation Combined with Drugs on Rebleeding and Mortality in Cirrhotic Patients: A Network Meta-Analysis

  2017cites this paper
• Magnetic Resonance Elastography Shear Wave Velocity Correlates with Liver Fibrosis and Hepatic Venous Pressure Gradient in Adults with Advanced Liver Disease

  2017cites this paper
• Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases

  2017cites this paper
• Bacterial load and cytokine profile in patients with cirrhosis following therapy with proton pump inhibitors: a prospective cohort study

  2017cites this paper
• Prevention and management of gastroesophageal varices

  2017cites this paper
• Timing Affects Measurement of Portal Pressure Gradient After Placement of Transjugular Intrahepatic Portosystemic Shunts in Patients With Portal Hypertension.

  2017cites this paper
• Wilson disease: symptomatic liver therapy.

  2017cites this paper
• Portal Hypertension—Molecular Mechanisms

  2017cites this paper
• The Beneficial Effect of Beta‐Blockers in Patients With Cirrhosis, Portal Hypertension and Ascites

  2016cites this paper
• Management of gastrointestinal bleeding in patients with cirrhosis.

  2016cites this paper
• Evaluación de los factores determinantes del recuento de plaquetas en pacientes con cirrosis

  2016cites this paper
• The interpretation of hepatic venous pressure gradient tracings – excellent interobserver agreement unrelated to experience

  2016cites this paper
• Secondary Prophylaxis in Special Patient Populations

  2016cites this paper
• Evaluación de la hipertensión portal clínicamente significativa mediante elastografía hepática

  2016cites this paper
• PORTAL HYPERTENSION TREATMENT WITH CANDESARTAN PLUS PROPRANOLOL FOR NINE MONTHS RESTORES NORMAL PORTAL CIRCULATION HEMODYNAMIC PATTERN.

  2016cites this paper
• Risk and Predictors of Variceal Bleeding in Cirrhosis Patients Receiving Primary Prophylaxis With Non-Selective Beta-Blockers

  2016cites this paper
• Endoscopic Band Ligation in Primary Prophylaxis

  2016cites this paper
• Consenso Mexicano de Hipertensión Portal

  2016cites this paper
• XXXII CONGRESO NACIONAL DE LA ASOCIACIÓN ESPAÑOLA PARA EL ESTUDIO DEL HÍGADO

  2016cites this paper
• Free Hepatic Vein Pressure Is Not Useful to Calculate the Portal Pressure Gradient in Cirrhosis: A Morphologic and Hemodynamic Study.

  2016cites this paper
• Carvedilol versus non‐selective beta‐blockers for portal hypertension in cirrhosis

  2015cites this paper
• Mexican Consensus on Portal Hypertension

  2015cites this paper
• Portal vein thrombosis in cirrhosis: Controversies and latest developments.

  2015cites this paper
• Use of non-selective beta blockers in cirrhosis: the evidence we need before closing (or not) the window.

  2015cites this paper
• Impact of splenic circulation: non-invasive microbubble-based assessment of portal hemodynamics

  2015cites this paper
• Cirrhosis and portal hypertension: The importance of risk stratification, the role of hepatic venous pressure gradient measurement.

  2015cites this paper
• Esophageal Varices: Primary and Secondary Prophylaxis

  2015cites this paper
• Challenges and opportunities in the management of portal hypertension

  2015cites this paper
• Beta-blockers in cirrhosis and refractory ascites: a retrospective cohort study and review of the literature

  2015cites this paper
• Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview.

  2015cites this paper
• Treatment of Spontaneous Bacterial Peritonitis

  2015cites this paper
• A new Mdr2(-/-) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancer.

  2015cites this paper
• Clinical Evaluation and Prognosis

  2015cites this paper
• Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments.

  2015cites this paper
• Primary prophylaxis of variceal bleeding.

  2014cites this paper
• Nonselective β-blockers may induce development of portal vein thrombosis in cirrhosis.

  2014cites this paper
• Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.

  2014cites this paper
• Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trial.

  2014cites this paper
• Oral probiotic VSL#3 attenuates the circulatory disturbances of patients with cirrhosis and ascites

  2014cites this paper
• Evaluation on therapeutic effects of orthotopic liver transplantation by megnetic resonance imaging in patients with portal hypertension.

  2014cites this paper
• HVPG-Guided Prophylaxis

  2014cites this paper
• Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension

  2014cites this paper
• Assessment of risk of complications in cirrhosis using portal thallium scans.

  2014cites this paper
• Beta-blockers in liver cirrhosis

  2014cites this paper
• Noninvasive assessment of portal hypertension in cirrhosis: liver stiffness and beyond.

  2014cites this paper
• The study of hepatic hemodynamics: research activity or clinical tool?

  2013cites this paper